KLTO
Klotho Neurosciences Inc.

3,804
Mkt Cap
$29.04M
Volume
546,595.00
52W High
$3.91
52W Low
$0.1135
PE Ratio
-1.23
KLTO Fundamentals
Price
$0.3833
Prev Close
$0.4004
Open
$0.4124
50D MA
$0.5111
Beta
1.12
Avg. Volume
734,399.11
EPS (Annual)
-$0.3195
P/B
2.84
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
News Placeholder
Klotho Neurosciences Wins the 2025 BioTech Breakthrough 'Cell Therapy Innovation of the Year' Award
Klotho Neurosciences Wins the 2025 BioTech Breakthrough 'Cell Therapy Innovation of the Year' Award Klotho Neurosciences Wins the 2025 BioTech Breakthrough 'Cell Therapy Innovation of the Year' Award...
PR Newswire·1mo ago
News Placeholder
Klotho Neurosciences CEO to Attend Longevity Biotech 2025 in Boston
Klotho Neurosciences CEO to Attend Longevity Biotech 2025 in Boston Klotho Neurosciences CEO to Attend Longevity Biotech 2025 in Boston PR Newswire NEW YORK, Oct. 16, 2025 NEW YORK, Oct. 16, 2025...
PR Newswire·2mo ago
News Placeholder
Klotho Neurosciences Stock Jumps As FDA Grants Orphan Drug Tag To ALS Gene Therapy
The FDA’s Orphan Drug Designation offers incentives like seven years of U.S. market exclusivity, tax credits for clinical trials, and a waiver of the user fee for its ALS gene therapy.
Stocktwits·5mo ago
News Placeholder
Klotho Neurosciences Stock Skyrockets On Anti-Aging Gene Therapy Breakthrough: Retail Traders Over The Moon
The gene therapy, delivered via the AAV9 vector, showed positive effects in both standard and accelerated aging models.
Stocktwits·6mo ago
<
...
1
>

Latest KLTO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.